Total
0
Shares
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Healthcare tech company Pacific Knowledge Systems (PKS) renews key contracts and wins new clients
  • The company has seen a near complete contract renewal rate — keeping 99 per cent of its customers
  • Notably, this puts PKS ahead of expectations of recurrent revenue exceeding 70 per cent of total operating revenue
  • New contracts have been signed with Ramsay hospitals, which includes WA’s Joondalup and Hollywood Private hospitals, as well as Brisbane’s Greenslopes hospital
  • On the market this afternoon, PKS is up 6.41 per cent and is trading at 41.5 cents per share

Pacific Knowledge Systems (PKS) has successfully renewed key contracts and won new clients.

As the end of the current financial year is coming to a close, the healthcare technology company has seen a near complete contract renewal rate — keeping 99 per cent of its customers.

Notably, this puts PKS ahead of expectations of recurrent revenue exceeding 70 per cent of total operating revenue.

Major contract renewals for its data products, PICQ and RISQ, include Healthscope, St John of God, Cabrini and more. The company also renewed deals with state health departments, such as NSW, Victoria, South Australia, Northern Territory and Tasmania and a number of major health services in Queensland.

New contracts have been signed with Ramsay hospitals, which includes WA’s Joondalup and Hollywood Private hospitals, as well as Brisbane’s Greenslopes hospital.

“The company’s retention rate underlines the importance of PKS’ services to supporting healthcare clients and confirms how our best-practice data and decision support technologies assist improvement in the quality and efficiency of clinical outcomes,” CEO Tim Kelsey said.

“It is a privilege to serve health services in Australia and around the world as they continue to manage the impact of COVID-19 on their communities.

“The strength of renewals and new business in the final months of this financial year underscores the value that clients put on our data and decision support services.”

On the market this afternoon, PKS is up 6.41 per cent and is trading at 41.5 cents per share at 2:20 pm AEST.

PKS by the numbers
More From The Market Herald
APM (ASX:APM) - CEO, Michael Anghie

" APM Human Services (ASX:APM) expands, acquiring Lifecare

APM Human Services International (APM) has acquired physiotherapy and home care group Lifecare for $68 million.
Resonance Health (ASX:RHT)

" Resonance Health (ASX:RHT) submits LiverSmart to FDA

Resonance Health (RHT) has submitted its LiverSmart device to the Food and Drug Administration (FDA) for US regulatory clearance.
Dotz Nano (ASX:DTZ) - CEO, Gideon Shmuel

" Dotz Nano (ASX:DTZ) signs Malaysian distribution deal for COVID-19 tests

Dotz Nano (DTZ) has entered into a distribution agreement with ScienceVision to promote, sell and distribute its COVID-19 virus detection technology in Malaysia.
Kazia Therapeutics (ASX:KZA) - CEO, Dr James Garner

" Kazia Therapeutics (ASX:KZA) releases “positive” second-phase study results for brain cancer treatment

Kazia Therapeutics (KZA) has opened the trading day green after reporting positive final results from a second-phase clinical study of its paxalisib drug